No Clinically Significant Interaction Between Linezolid and Perfalgan (Paracetamol)
There is no documented drug interaction between linezolid and Perfalgan (paracetamol/acetaminophen), and these medications can be safely co-administered without dose adjustment.
Evidence Base
The FDA drug label for linezolid provides comprehensive documentation of drug interactions, and paracetamol/acetaminophen is notably absent from this list 111. The documented interactions with linezolid specifically involve:
- Monoamine oxidase-related interactions: Serotonergic agents (SSRIs, antidepressants) and adrenergic agents (pseudoephedrine, phenylpropanolamine, tyramine-containing foods)
- CYP450 inducers: Rifampin (causes 32% decrease in linezolid AUC)
- Other antibiotics: No significant interactions with aztreonam or gentamicin
A comprehensive 2024 systematic review examining drug-drug interactions affecting linezolid pharmacokinetics identified rifampicin, levothyroxine, venlafaxine, phenobarbital, clarithromycin, digoxin, cyclosporine, proton pump inhibitors, and amiodarone as interacting medications 2. Paracetamol was not identified as an interacting drug.
Mechanism Considerations
Paracetamol does not:
- Affect monoamine oxidase activity (linezolid's primary interaction mechanism)
- Induce or inhibit CYP450 enzymes significantly
- Act as a P-glycoprotein modulator (the proposed mechanism for many linezolid interactions 2)
Linezolid is not metabolized by CYP450 enzymes and does not induce or inhibit clinically significant CYP isoforms 1, eliminating the typical metabolic interaction pathway with paracetamol.
Clinical Implications
You can prescribe these medications together without:
- Dose adjustments for either drug
- Additional monitoring beyond standard parameters for each medication individually
- Concerns about altered efficacy or toxicity from the combination
Important Monitoring Considerations
While the combination is safe, monitor for linezolid-specific adverse effects independently:
- Thrombocytopenia: Weekly platelet counts, especially with treatment >2 weeks 34
- Peripheral and optic neuropathy: Clinical assessment (these are not reversible) 3
- Bone marrow suppression: Complete blood counts
- Lactic acidosis: In prolonged therapy
The 2024 literature confirms that aspirin, not paracetamol, increases thrombocytopenia risk with linezolid 54.